Marie Terroir-Cassou-Mounat

Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial

Étienne Garin, Lambros Tselikas, Boris Guiu et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 604 citations

Medicine, Oncology, Radiation Oncology +17

A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer

Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud et al. · Clinical Cancer Research · 2023 · 94 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Major impact of personalized dosimetry using 90Y loaded glass microspheres SIRT in HCC: Final overall survival analysis of a multicenter randomized phase II study (DOSISPHERE-01).

Étienne Garin, Lambros Tzelikas, Boris Guiu et al. · Journal of Clinical Oncology · 2020 · 31 citations

Medicine, Nuclear Medicine, Oncology +17

MERAIODE: A Redifferentiation Phase II Trial With Trametinib and Dabrafenib Followed by Radioactive Iodine Administration for Metastatic Radioactive Iodine Refractory Differentiated Thyroid Cancer Patients With a BRAFV600E Mutation (NCT 03244956)

Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud et al. · Journal of the Endocrine Society · 2021 · 30 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations

Christophe Willekens, Aline Renneville, Sophie Broutin et al. · Leukemia · 2018 · 21 citations

Medicine, Molecular Genetics, Oncology +17